eplerenone 25 MG Oral Tablet [Inspra]
eplerenone
RxCUI: 402106
What the CMS Formulary Data Shows for eplerenone 25 MG Oral Tablet [Inspra]
Per the CMS 2026 Part D formulary file, eplerenone 25 MG Oral Tablet [Inspra] (RxNorm concept RXCUI 402106, generic name eplerenone) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to eplerenone 25 MG Oral Tablet [Inspra] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 67,162 Part D beneficiaries filled eplerenone 25 MG Oral Tablet [Inspra] in 2023, with total plan-and-beneficiary spending of $29,814,576 and an average per-beneficiary annual cost of $443.92. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry eplerenone 25 MG Oral Tablet [Inspra] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 2
- Coverage rate
- 0%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 67,162
- Total spending
- $29,814,576
- Avg per beneficiary
- $443.92
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering eplerenone 25 MG Oral Tablet [Inspra]
2 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is eplerenone 25 MG Oral Tablet [Inspra] covered by Medicare Part D?
Yes, eplerenone 25 MG Oral Tablet [Inspra] is covered by 2 Medicare Part D plans (0% of all Part D formularies).
What tier is eplerenone 25 MG Oral Tablet [Inspra] on Medicare Part D plans?
eplerenone 25 MG Oral Tablet [Inspra] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does eplerenone 25 MG Oral Tablet [Inspra] require prior authorization?
0% of Part D formularies require prior authorization for eplerenone 25 MG Oral Tablet [Inspra]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on eplerenone 25 MG Oral Tablet [Inspra]?
In 2023, total Medicare Part D spending on eplerenone 25 MG Oral Tablet [Inspra] was $29,814,576, covering 67,162 beneficiaries. The average spend per beneficiary was $443.92.
Read our methodology - how this data is sourced, computed, and verified.